Summary
The fund’s investment objective is to grow capital in the long-term through investing in small- and mid-size companies.
The investment process starts with a list of companies included in the benchmark Russell 2500 Value Index. The research team then with the help of fundamental analysis and quantitative techniques identifies companies that are trading at a discount to their industry peers and are expected to deliver attractive long term growth.
The fund has the flexibility to invest in companies with market capitali
Link
Directors
Sep 11, 2023- Terence J. Toth
- Jack B. Evans
- William C. Hunter
- Albin F. Moschner
- John K. Nelson
- Margaret L. Wolff
- Robert L. Young
- Matthew Thornton III
- Amy B. R. Lancellotta
- Joanne T. Medero
Chief Compliance Officer
- Brett E. Black
Fund Manager(s)
- Andrew Hwang
- Thomas Lavia
Price
Company Name |
Holding |
| ADMA Biologics Inc | 4.37 % |
| BGC Group Inc | 3.11 % |
| Flowserve Corp | 2.51 % |
| United Therapeutics Corp | 2.37 % |
| Seagate Technology Holdings PLC | 2.31 % |
| nVent Electric PLC | 2.3 % |
| ITT Inc | 2.29 % |
| Iron Mountain Inc | 2.28 % |
| Crane Co | 2.26 % |
| Curtiss-Wright Corp | 2.22 % |
| More |
Documents
Performance
YTD
3.1%
3 Year
-1.26%
5 Year
32.52%
Best
37.39%
2013
Worst
-45.4%
2008
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | 9.2% | 1.8% | -1% | 0.4% | -33.6% | 15.6% | -1.6% | 3.6% | 1.5% | 1.7% |
| Q2 | -3.6% | 4.3% | -14.8% | 25.8% | 19.2% | 2.2% | 8.8% | -2.5% | - | -2.3% |
| Q3 | - | -2.8% | -2.6% | -19.2% | 2.5% | 0.7% | -0.3% | 3% | 6% | -12.5% |
| Q4 | - | 10.8% | 6.7% | 8.5% | 23.1% | 6.1% | -22.8% | 4.1% | 10.8% | 7.7% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -1.3% | 3.8% | 6.6% | -4.3% | - | - | - | - | - | - | - | - |
| 2023 | 6.2% | - | -4.1% | -1% | -1.6% | 7% | 3.7% | -2.4% | -4% | -3.2% | 7.4% | 5.2% |
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3% | 13% | -12% | 11% | -0% | 29% | -20% | 9% | 0% | -6% |
Alpha
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| NSMCX | 3% | 13% | -12% | 11% | -0% | 29% | -20% | 9% | - | -6% |
| Russell Midcap | - | - | -3% | 26% | 3% | 24% | -14% | 11% | 17% | -7% |
| Alpha | 3% | 13% | -10% | -15% | -3% | 5% | -6% | -2% | - | 1% |